Back to Agenda
Session 8: Clinical Trial Disclosure - FDA Enforcement Activities
Session Chair(s)
Robert Paarlberg, MS
Principal
Paarlberg & Associates LLC, United States
Speaker(s)
Presenter
Jarilyn Dupont, JD
FDA, United States
Director of Regulatory Policy, Office of Policy, OC
Presenter
Mark Barnes, JD, LLM
Ropes & Gray, LLP, United States
Partner
Presenter
Chris Galvin
Department of Health and Human Services, United States
Office of Inspector General
Have an account?